We are live on ! Find out more
GLA

Great Lakes Advisors Portfolio holdings

AUM $12.1B
1-Year Est. Return 29.3%
This Fund
S&P 500
This Quarter Est. Return
+20.41%
1 Year Est. Return
+29.3%
3 Year Est. Return
+85.9%
5 Year Est. Return
+114.32%
10 Year Est. Return
+414.57%
AUM
$5.53B
AUM Growth
+$799M
Cap. Flow
-$23.9M
Cap. Flow %
-0.43%
Top 10 Hldgs %
12.93%
Holding
676
New
99
Increased
203
Reduced
294
Closed
39

Top Sells

Rank Stock Value
1
ROL icon
Rollins
ROL
+$24.7M
2
PNR icon
Pentair
PNR
+$24.4M
3
RVTY icon
Revvity
RVTY
+$23.3M
4
MANH icon
Manhattan Associates
MANH
+$19.5M
5
COR
Coresite Realty Corporation
COR
+$19.4M

Sector Composition

Rank Sector Weight
1 Financials 15.02%
2 Healthcare 14.34%
3 Consumer Discretionary 12.85%
4 Technology 10.88%
5 Industrials 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBUX icon
201
Starbucks
SBUX
$119B
$6.07M 0.11%
56,749
+3,635
+7% +$347K
IDXX icon
202
Idexx Laboratories
IDXX
$44.9B
$6.06M 0.11%
12,121
-251
-2% -$112K
JNJ icon
203
Johnson & Johnson
JNJ
$640B
$6.05M 0.11%
38,424
+236
+0.6% +$34.8K
PEP icon
204
PepsiCo
PEP
$196B
$6.02M 0.11%
40,582
-902
-2% -$128K
STZ icon
205
Constellation Brands
STZ
$22.5B
$6M 0.11%
27,391
-7,571
-22% -$1.49M
SPGI icon
206
S&P Global
SPGI
$124B
$5.96M 0.11%
18,146
-3,622
-17% -$1.22M
PAYX icon
207
Paychex
PAYX
$43.4B
$5.86M 0.11%
62,840
-33
-0.1% -$2.93K
BLUE
208
DELISTED
bluebird bio
BLUE
$5.84M 0.11%
10,428
-12,158
-54% -$7.71M
BMRN icon
209
BioMarin Pharmaceuticals
BMRN
$11.9B
$5.82M 0.11%
66,345
-1,268
-2% -$101K
CRMT icon
210
America's Car Mart
CRMT
$25.9M
$5.73M 0.1%
52,184
-2,158
-4% -$217K
XENT
211
DELISTED
Intersect ENT, Inc
XENT
$5.72M 0.1%
250,019
-8,823
-3% -$168K
MHO icon
212
M/I Homes
MHO
$3.95B
$5.71M 0.1%
128,994
-4,240
-3% -$191K
LW icon
213
Lamb Weston
LW
$7.42B
$5.64M 0.1%
71,593
-3,314
-4% -$241K
GIL icon
214
Gildan
GIL
$9.49B
$5.62M 0.1%
200,544
-8,043
-4% -$198K
FBC
215
DELISTED
Flagstar Bancorp, Inc. New
FBC
$5.59M 0.1%
137,236
-4,074
-3% -$140K
AMD icon
216
Advanced Micro Devices
AMD
$700B
$5.58M 0.1%
60,811
+21,784
+56% +$1.88M
BNY
217
Bank of New York Mellon
BNY
$103B
$5.51M 0.1%
+129,867
New +$4.99M
ALKS icon
218
Alkermes
ALKS
$8.11B
$5.48M 0.1%
274,687
-393,026
-59% -$7.19M
ADI icon
219
Analog Devices
ADI
$172B
$5.46M 0.1%
37,001
+100
+0.3% +$13.3K
TROW icon
220
T. Rowe Price
TROW
$25.5B
$5.46M 0.1%
36,035
+15,373
+74% +$2.2M
XRAY icon
221
Dentsply Sirona
XRAY
$2.84B
$5.39M 0.1%
102,982
+4,762
+5% +$235K
AXS icon
222
AXIS Capital
AXS
$7.73B
$5.37M 0.1%
106,523
-2,661
-2% -$129K
ISBC
223
DELISTED
Investors Bancorp, Inc.
ISBC
$5.36M 0.1%
507,721
-50,246
-9% -$459K
BDX icon
224
Becton Dickinson
BDX
$46.4B
$5.35M 0.1%
21,918
-16,822
-43% -$3.92M
JLL icon
225
Jones Lang LaSalle
JLL
$15.8B
$5.3M 0.1%
35,707
-14,810
-29% -$1.9M

Similar funds

Great Lakes Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Great Lakes Advisors held 676 positions worth $5.53B, up 17% from $4.73B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Great Lakes Advisors's Q4 2020 filing shows 99 new, 203 increased, 294 reduced and 39 closed positions. Its largest new stake was Acadia Pharmaceuticals: 450,514 shares worth $24.1M. The largest sale was Rollins, an estimated $24.7M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Great Lakes Advisors's largest Q4 2020 buy was Acadia Pharmaceuticals: 450,514 shares worth $24.1M.
  • Great Lakes Advisors added most to Cisco in Q4 2020, an estimated $32.6M increase.
  • Great Lakes Advisors's biggest Q4 2020 reduction was Pentair, cutting an estimated $24.4M.
  • Great Lakes Advisors fully exited Rollins in Q4 2020, selling an estimated $24.7M.
  • Great Lakes Advisors's ten largest holdings make up 13% of its $5.53B portfolio in Q4 2020.
  • Great Lakes Advisors opened 99 new positions and closed 39 in Q4 2020.
  • Great Lakes Advisors's portfolio value rose 17% quarter-over-quarter to $5.53B.

Based on Great Lakes Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.